These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11836603

  • 1. Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy.
    Seto M, Yamazaki T, Sonoda J, Matsumine A, Shinto Y, Uchida A.
    Oncol Rep; 2002; 9(2):337-40. PubMed ID: 11836603
    [Abstract] [Full Text] [Related]

  • 2. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 3. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy.
    Shirakawa T, Ko SC, Gardner TA, Cheon J, Miyamoto T, Gotoh A, Chung LW, Kao C.
    Cancer Gene Ther; 1998 Jul; 5(5):274-80. PubMed ID: 9824046
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 Jul; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer.
    Hayashi S, Emi N, Yokoyama I, Namii Y, Uchida K, Takagi H.
    Cancer Gene Ther; 1997 Dec; 4(6):339-44. PubMed ID: 9408603
    [Abstract] [Full Text] [Related]

  • 9. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model].
    Zhou JF, Chen G, Lu YP, Wang SX, Ma D.
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319
    [Abstract] [Full Text] [Related]

  • 10. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [Abstract] [Full Text] [Related]

  • 11. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
    Sharma S, Miller PW, Stolina M, Zhu L, Huang M, Paul RW, Dubinett SM.
    Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
    [Abstract] [Full Text] [Related]

  • 12. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A, Määttä AM, Pasanen T, Tulimäki K, Wahlfors J.
    Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374
    [Abstract] [Full Text] [Related]

  • 13. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.
    Ko SC, Cheon J, Kao C, Gotoh A, Shirakawa T, Sikes RA, Karsenty G, Chung LW.
    Cancer Res; 1996 Oct 15; 56(20):4614-9. PubMed ID: 8840973
    [Abstract] [Full Text] [Related]

  • 14. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr 15; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 15. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Cao ZH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 15; 26(2):84-7. PubMed ID: 12783658
    [Abstract] [Full Text] [Related]

  • 16. Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM.
    Yamaguchi Y, Takashima I, Hihara J, Ohta K, Shimizu K, Minami K, Yoshida K, Toge T.
    Int J Mol Med; 2000 Aug 15; 6(2):185-90. PubMed ID: 10891564
    [Abstract] [Full Text] [Related]

  • 17. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
    Balzarini J, Ostrowski T, Goslinski T, De Clercq E, Golankiewicz B.
    Gene Ther; 2002 Sep 15; 9(17):1173-82. PubMed ID: 12170381
    [Abstract] [Full Text] [Related]

  • 18. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar 15; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.
    Kumagai T, Tanio Y, Osaki T, Hosoe S, Tachibana I, Ueno K, Kijima T, Horai T, Kishimoto T.
    Cancer Res; 1996 Jan 15; 56(2):354-8. PubMed ID: 8542591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.